These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10965283)

  • 1. Correlates of symptom dimensions in schizophrenia obtained with the Spanish version of the Manchester scale.
    Tabarés R; Sanjuán J; Gómez-Beneyto M; Leal C
    Psychopathology; 2000; 33(5):259-64. PubMed ID: 10965283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopathological dimensions in schizophrenia.
    Cuesta MJ; Peralta V
    Schizophr Bull; 1995; 21(3):473-82. PubMed ID: 7481577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premorbid personality in psychoses.
    Cuesta MJ; Peralta V; Caro F
    Schizophr Bull; 1999; 25(4):801-11. PubMed ID: 10667749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An exploration of the psychometric properties of the French version of the Positive and Negative Syndrome Scale.
    Lançon C; Aghababian V; Llorca PM; Bernard D; Auquier P
    Can J Psychiatry; 1999 Nov; 44(9):893-900. PubMed ID: 10584159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
    Loas G; Noisette C; Legrand A; Delahousse J
    Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of positive and negative symptoms in first episode schizophrenia.
    Vázquez-Barquero JL; Lastra I; Cuesta Nuñez MJ; Herrera Castanedo S; Dunn G
    Br J Psychiatry; 1996 Jun; 168(6):693-701. PubMed ID: 8773811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS).
    Valiente-Gómez A; Mezquida G; Romaguera A; Vilardebò I; Andrés H; Granados B; Larrubia J; Pomarol-Clotet E; McKenna PJ; Sarró S; Bernardo M
    Schizophr Res; 2015 Aug; 166(1-3):104-9. PubMed ID: 26116328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia.
    Sarró S; Dueñas RM; Ramírez N; Arranz B; Martínez R; Sánchez JM; González JM; Saló L; Miralles L; San L
    Schizophr Res; 2004 Jun; 68(2-3):349-56. PubMed ID: 15099616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Validation of positive and negative symptom scale (PANSS) in a sample of Spanish schizophrenic patients].
    Peralta Martín V; Cuesta Zorita MJ
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1994; 22(4):171-7. PubMed ID: 7810373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demographics, family history, premorbid functioning, developmental characteristics, and course of patients with deteriorated affective disorder.
    Vocisano C; Klein DN; Keefe RS; Dienst ER; Kincaid MM
    Am J Psychiatry; 1996 Feb; 153(2):248-55. PubMed ID: 8561207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom dimensions and their association with outcome and treatment setting in long-term schizophrenia. Results of the DSP project.
    Salokangas RK; Honkonen T; Stengård E; Koivisto AM
    Nord J Psychiatry; 2002; 56(5):319-27. PubMed ID: 12470304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychometric properties of PANSS (Positive and Negative Syndrome Scale) in the French version in a sample of schizophrenic patients].
    Lançon C; Auquier P; Llorca PM; Martinez JL; Bougerol T; Scotto JC
    Encephale; 1997; 23(1):1-9. PubMed ID: 9172961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [French validation of the Verona Service Satisfaction Scale-VSSS-54F].
    Corbière M; Lesage A; Lauzon S; Ricard N; Reinharz D
    Encephale; 2003; 29(2):110-8. PubMed ID: 14567162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific cerebral perfusion patterns in three schizophrenia symptom dimensions.
    Stegmayer K; Strik W; Federspiel A; Wiest R; Bohlhalter S; Walther S
    Schizophr Res; 2017 Dec; 190():96-101. PubMed ID: 28320578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between insight and self-reported quality of life among shizophrenic patients].
    Aghababian V; Auquier P; Baumstarck-Barrau K; Lançon C
    Encephale; 2011 Jun; 37(3):162-71. PubMed ID: 21703431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four symptom dimensions in outpatients with schizophrenia.
    Villalta-Gil V; Vilaplana M; Ochoa S; Dolz M; Usall J; Haro JM; Almenara J; González JL; Lagares C;
    Compr Psychiatry; 2006; 47(5):384-8. PubMed ID: 16905401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor solution of the BPRS-expanded version in schizophrenic outpatients living in five European countries.
    Ruggeri M; Koeter M; Schene A; Bonetto C; Vàzquez-Barquero JL; Becker T; Knapp M; Knudsen HC; Tansella M; Thornicroft G;
    Schizophr Res; 2005 Jun; 75(1):107-17. PubMed ID: 15820329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Minor neurological and physical anomalies in patients with first-episode psychosis].
    Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
    Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.